You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting.  Sign up here. CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the...

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting. “We’re seeing this expansion in modalities. We have more types of modalities...

CHICAGO — The Food and Drug Administration’s top oncologist reiterated that the agency doesn’t want drugmakers applying for approval with data from trials solely run in a single country such as China, but instead wants to see companies conducting studies across the world. The comments by Richard Pazdur, director of the FDA’s Oncology Center of Excellence,...

CHICAGO — Corbus Pharmaceuticals is the second best-performing biotech stock this year, thanks to investor interest in an antibody-drug conjugate candidate, or ADC, called CRB-701 with the potential to be better tolerated than Padcev, an ADC treatment bladder cancer that Pfizer acquired as part of its $43 billion Seagen deal. On Saturday, Corbus updated...

CHICAGO — People can be mightily reluctant to get a colonoscopy for reasons like cost, language barriers, or fear of what the exam might discover. One of the best counters to such barriers are patient navigators who can help resolve most such reasons. The trouble is that there are only so many navigators at a given cancer center. Scientists at Montefiore...

To encourage robust, good-faith discussion about issues raised in First Opinion, STAT publishes selected Letters to the Editor received in response to these essays. Submit a Letter to the Editor here, or find the submission form at the end of any First Opinion essay. “Digital health: A case of mistaken identity” by Omar ManejwalaRead the rest…